In addition, identifying the presence of recurrent and/or none PALB2 PVs/LPVs will help in understanding the contribution to breast cancer and ovarian cancer risk and tailor the best preventive and treatment option of PALB2 carriers from Middle Eastern ethnicity. Here, PALB2 is linked to breast carcinoma.